Zoetis, Inc. (ZTS)
81.03
-0.97
(-1.18%)
USD |
NYSE |
Oct 23, 16:00
81.00
-0.03
(-0.04%)
After-Hours: 20:00
Zoetis Market Cap : 33.56B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 33.56B |
| October 22, 2026 | 33.96B |
| October 21, 2026 | 32.97B |
| October 20, 2026 | 33.15B |
| October 19, 2026 | 32.96B |
| October 16, 2026 | 32.88B |
| October 15, 2026 | 32.48B |
| October 14, 2026 | 31.18B |
| October 13, 2026 | 30.77B |
| October 12, 2026 | 31.33B |
| October 09, 2026 | 30.98B |
| October 08, 2026 | 30.27B |
| October 07, 2026 | 29.63B |
| October 06, 2026 | 29.54B |
| October 05, 2026 | 29.57B |
| October 02, 2026 | 28.86B |
| October 01, 2026 | 28.62B |
| September 30, 2026 | 28.92B |
| September 29, 2026 | 29.12B |
| September 28, 2026 | 29.58B |
| September 25, 2026 | 29.43B |
| September 24, 2026 | 29.10B |
| September 23, 2026 | 29.66B |
| September 22, 2026 | 30.18B |
| September 21, 2026 | 29.54B |
| Date | Value |
|---|---|
| September 18, 2026 | 29.57B |
| September 17, 2026 | 30.24B |
| September 16, 2026 | 30.23B |
| September 15, 2026 | 30.41B |
| September 14, 2026 | 30.51B |
| September 11, 2026 | 30.22B |
| September 10, 2026 | 30.18B |
| September 09, 2026 | 30.36B |
| September 08, 2026 | 30.47B |
| September 04, 2026 | 31.40B |
| September 03, 2026 | 31.60B |
| September 02, 2026 | 31.55B |
| September 01, 2026 | 31.99B |
| August 31, 2026 | 31.93B |
| August 28, 2026 | 32.03B |
| August 27, 2026 | 31.07B |
| August 26, 2026 | 32.11B |
| August 25, 2026 | 32.01B |
| August 24, 2026 | 31.96B |
| August 21, 2026 | 32.19B |
| August 20, 2026 | 31.07B |
| August 19, 2026 | 31.76B |
| August 18, 2026 | 30.63B |
| August 17, 2026 | 30.22B |
| August 14, 2026 | 30.56B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 358.62B |
| Phibro Animal Health Corp. | 1.574B |
| Eli Lilly & Co. | 1.199T |
| Pfizer Inc. | 171.14B |
| Bristol Myers Squibb Co. | 125.60B |
Market Cap Related Metrics
| PE Ratio | 13.33 |
| PS Ratio | 3.665 |
| PEG Ratio | 2.452 |
| Price to Book Value | 10.66 |
| Price to Free Cash Flow | 14.74 |
| Price | 81.03 |
| Earnings Yield | 7.50% |
| PEGY Ratio | 1.663 |
| Operating PE Ratio | 9.735 |
| Normalized PE Ratio | 12.90 |